Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Mini Review
  • Published:

Supine blood pressure measurement and its emerging role in cardiovascular risk stratification

Hypertension Research volume 49, pages 734–739 (2026)Cite this article

Abstract

The measurement of an individual’s blood pressure (BP) while he or she is in a seated position is the standard BP measurement method. The significance of BP measurements obtained from an individual while he or she is in the supine position has also been described. Supine BP values are usually lower than seated BP values, and thus the condition of high supine BP is abnormal and called ‘supine hypertension.’ Although the mechanisms that underlie supine hypertension are not completely understood, it has been speculated that fluid retention and abnormal sympathetic nervous activity can lead to supine hypertension. Hypertension-mediated organ damage and cardiovascular events have been shown to be associated with supine hypertension; not only supine hypertension with neurogenic orthostatic hypotension but also supine hypertension without it. The treatment of supine hypertension has not been established. Considering the pathophysiological background of this condition, the use of antihypertensive drugs and bedtime dosing may be effective. Further research is necessary to clarify the significance of supine hypertension and to establish the optimal treatment for this condition.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on SpringerLink
  • Instant access to the full article PDF.

USD 39.95

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Aamir A, Mohammed R, Shaffi K, Khalil K. Syndrome of supine hypertension with orthostatic hypotension: pathophysiology and clinical approach. Curr Cardiol Rev. 2020;16:48–54.

    Article  Google Scholar 

  2. Chisholm P, Anpalahan M. Orthostatic hypotension: pathophysiology, assessment, treatment and the paradox of supine hypertension. Intern Med J. 2017;47:370–9.

    Article  PubMed  Google Scholar 

  3. Jordan J, Fanciulli A, Tank J, Calandra-Buonaura G, Cheshire WP, Cortelli P, et al. Management of supine hypertension in patients with neurogenic orthostatic hypotension: scientific statement of the American Autonomic Society, European Federation of Autonomic Societies, and the European Society of Hypertension. J Hypertens. 2019;37:1541–6.

    Article  CAS  PubMed  Google Scholar 

  4. Kario K, Hoshide S, Kabutoya T, Nishizawa M, Yamagiwa K, Kawashima A, et al. Impact of vascular biomarkers and supine hypertension on cardiovascular outcomes in hypertensive patients: first results from the Cardiovascular Prognostic COUPLING Study in Japan. Hypertens Res. 2025;48:693–701.

    Article  PubMed  Google Scholar 

  5. Giao DM, Col H, Larbi Kwapong F, Turkson-Ocran RA, Ngo LH, Cluett JL, et al. Supine blood pressure and risk of cardiovascular disease and mortality. JAMA Cardiol. 2025;10:265–75.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Umemura S, Arima H, Arima S, Asayama K, Dohi Y, Hirooka Y, et al. The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2019). Hypertens Res. 2019;42:1235–481.

    Article  PubMed  Google Scholar 

  7. McEvoy JW, McCarthy CP, Bruno RM, Brouwers S, Canavan MD, Ceconi C, et al. 2024 ESC Guidelines for the management of elevated blood pressure and hypertension: developed by the task force on the management of elevated blood pressure and hypertension of the European Society of Cardiology (ESC) and endorsed by the European Society of Endocrinology (ESE) and the European Stroke Organisation (ESO). Eur Heart J. 2024;45:3912–4018.

    Article  PubMed  Google Scholar 

  8. Whelton PK, Carey RM, Aronow WS, Casey DE, Collins KJ, Dennison Himmelfarb C, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension. 2018;71:e13–e115.

    CAS  PubMed  Google Scholar 

  9. Fanciulli A, Jordan J, Biaggioni I, Calandra-Buonaura G, Cheshire WP, Cortelli P, et al. Consensus statement on the definition of neurogenic supine hypertension in cardiovascular autonomic failure by the American Autonomic Society (AAS) and the European Federation of Autonomic Societies (EFAS) : Endorsed by the European Academy of Neurology (EAN) and the European Society of Hypertension (ESH). Clin Auton Res. 2018;28:355–62.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Gibbons CH, Schmidt P, Biaggioni I, Frazier-Mills C, Freeman R, Isaacson S, et al. The recommendations of a consensus panel for the screening, diagnosis, and treatment of neurogenic orthostatic hypotension and associated supine hypertension. J Neurol. 2017;264:1567–82.

    Article  PubMed  PubMed Central  Google Scholar 

  11. Smit AA, Halliwill JR, Low PA, Wieling W. Pathophysiological basis of orthostatic hypotension in autonomic failure. J Physiol. 1999;519:1–10.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Kario K, Chen CH, Park S, Park CG, Hoshide S, Cheng HM, et al. Consensus document on improving hypertension management in Asian patients, taking into account Asian characteristics. Hypertension. 2018;71:375–82.

    Article  CAS  PubMed  Google Scholar 

  13. Kotsis V, Stabouli S, Bouldin M, Low A, Toumanidis S, Zakopoulos N. Impact of obesity on 24-hour ambulatory blood pressure and hypertension. Hypertension. 2005;45:602–7.

    Article  CAS  PubMed  Google Scholar 

  14. Kimura G, Saito F, Kojima S, Yoshimi H, Abe H, Kawano Y, et al. Renal function curve in patients with secondary forms of hypertension. Hypertension. 1987;10:11–5.

    Article  CAS  PubMed  Google Scholar 

  15. Kario K. Nocturnal hypertension: new technology and evidence. Hypertension. 2018;71:997–1009.

    Article  CAS  PubMed  Google Scholar 

  16. Nolde JM, Kiuchi MG, Carnagarin R, Frost S, Kannenkeril D, Lugo-Gavidia LM, et al. Supine blood pressure-A clinically relevant determinant of vascular target organ damage in hypertensive patients. J Clin Hypertens. 2020;23:44–52.

    Article  Google Scholar 

  17. Liu J, Li Y, Asayama K, Zhang XJ, Cheng HM, Park S, et al. Asian expert consensus on nocturnal hypertension management. Hypertension. 2025;82:945–56.

    Article  CAS  PubMed  Google Scholar 

  18. Wang F, Zhao H, Yang C, Kong G, Song L, Li C, et al. Association of blood pressure in the supine position with target organ damage in subjects over 60 years old. J Int Med Res. 2017;45:123–33.

    Article  PubMed  Google Scholar 

  19. Frewen J, Finucane C, Savva GM, Boyle G, Kenny RA. Orthostatic hypotension is associated with lower cognitive performance in adults aged 50 plus with supine hypertension. J Gerontol A Biol Sci Med Sci. 2014;69:878–85.

    Article  PubMed  Google Scholar 

  20. Newman L, O’Connor JD, Romero-Ortuno R, Reilly RB, Kenny RA. Supine hypertension is associated with an impaired cerebral oxygenation response to orthostasis: finding from the Irish Longitudinal Study on ageing. Hypertension. 2021;78:210–9.

    Article  CAS  PubMed  Google Scholar 

  21. Baik I, Kim NH, Kim SH, Shin C. Association of blood pressure measurements in sitting, supine, and standing positions with the 10-year risk of mortality in Korean adults. Epidemiol Health. 2023;45:e2023055.

    Article  PubMed  PubMed Central  Google Scholar 

  22. Juraschek SP, Cortez MM, Flack JM, Ghazi L, Kenny RA, Rahman M, et al. Orthostatic hypotension in adults with hypertension: a scientific statement from the American Heart Association. Hypertension. 2024;81:e16–e30.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Raber I, Belanger MJ, Farahmand R, Aggarwal R, Chiu N, Al Rifai M, et al. Orthostatic hypotension in hypertensive adults: Harry Goldblatt Award for early career investigators 2021. Hypertension. 2022;79:2388–96.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Park JW, Okamoto LE, Biaggioni I. Advances in the pathophysiology and management of supine hypertension in patients with neurogenic orthostatic hypotension. Curr Hypertens Rep. 2022;24:45–54.

    Article  PubMed  PubMed Central  Google Scholar 

  25. Okamoto LE, Celedonio JE, Smith EC, Gamboa A, Shibao CA, Diedrich A, et al. Local passive heat for the treatment of hypertension in autonomic failure. J Am Heart Assoc. 2021;10:e018979.

    Article  PubMed  PubMed Central  Google Scholar 

  26. Arnold AC, Okamoto LE, Gamboa A, Shibao C, Raj SR, Robertson D, et al. Angiotensin II, independent of plasma renin activity, contributes to the hypertension of autonomic failure. Hypertension. 2013;61:701–6.

    Article  CAS  PubMed  Google Scholar 

  27. Arnold AC, Okamoto LE, Gamboa A, Black BK, Raj SR, Elijovich F, et al. Mineralocorticoid receptor activation contributes to the supine hypertension of autonomic failure. Hypertension. 2016;67:424–9.

    Article  CAS  PubMed  Google Scholar 

  28. Okamoto LE, Gamboa A, Shibao CA, Arnold AC, Choi L, Black BK, et al. Nebivolol, but not metoprolol, lowers blood pressure in nitric oxide-sensitive human hypertension. Hypertension. 2014;64:1241–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Shibao C, Gamboa A, Abraham R, Raj SR, Diedrich A, Black B, et al. Clonidine for the treatment of supine hypertension and pressure natriuresis in autonomic failure. Hypertension. 2006;47:522–6.

    Article  CAS  PubMed  Google Scholar 

  30. Komori T, Eguchi K, Saito T, Hoshide S, Kario K. Riser pattern is a novel predictor of adverse events in heart failure patients with preserved ejection fraction. Circ J. 2017;81:220–6.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Cardiovascular Medicine, Department of Medicine, Jichi Medical University School of Medicine, Tochigi, Japan

    Takahiro Komori

Authors
  1. Takahiro Komori
    View author publications

    Search author on:PubMed Google Scholar

Corresponding author

Correspondence to Takahiro Komori.

Ethics declarations

Conflict of interest

The author declares no competing interests.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Komori, T. Supine blood pressure measurement and its emerging role in cardiovascular risk stratification. Hypertens Res 49, 734–739 (2026). https://doi.org/10.1038/s41440-025-02531-2

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Version of record:

  • Issue date:

  • DOI: https://doi.org/10.1038/s41440-025-02531-2

Keywords

Search

Advanced search

Quick links